Search Within

Craig Nolan

Formats
  1. Meeting Abstract (30)
  2. Journal Article (28)
  3. Book Section (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (42)
  2. GSK Faculty (31)
  3. Human Oncology and Pathogenesis Program (29)
  4. Radiology, Department of (22)
  5. Neuroradiology Service (20)
  6. Population Sciences Research Program (19)

More Groups

People
  1. Lisa De Angelis (40)
  2. Igor Gavrilovic (33)
  3. Thomas Kaley (31)
  4. Ingo Mellinghoff (29)
  5. Elena Pentsova (28)
  6. Christian Grommes (27)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Neuro-Oncology (19)
  2. Journal of Clinical Oncology (9)
  3. Blood (5)
  4. Clinical Cancer Research (4)
  5. Journal of Neuro-Oncology (4)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. Oxford University Press (22)
  2. American Society of Clinical Oncology (9)
  3. Springer (6)
  4. American Association for Cancer Research (5)
  5. American Society of Hematology (5)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Intramedullary spinal cord and leptomeningeal metastases from intracranial low-grade oligodendroglioma
    Journal Article

    Verma, N.; Nolan, C.; Hirano, M.; Young, R. J.
    Clinical Imaging (2014)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A. M. P.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Lacouture, M. E.; Holland, E. C.; Lassman, A. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
    Meeting Abstract

    Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Journal Article

    Omuro, A.; Chan, T. A.; Abrey, L. E.; Khasraw, M.; Reiner, A. S.; Kaley, T. J.; De Angelis, L. M.; Lassman, A. B.; Nolan, C. P.; Gavrilovic, I. T.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ro4929097 in combination with radiotherapy and temozolomide for newly diagnosed malignant glioma (MG): A pharmacokinetic (Pk) and pharmacodynamic (Pd) study
    Meeting Abstract

    Omuro, A.; Beal, K.; Ivy, P.; Gutin, P.; Wu, N.; Kaley, T.; Karimi, S.; DeAngelis, L.; Pentsova, E.; Nolan, C.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A.; Mellinghoff, I.; Nolan, C.; Gavrilovic, I.; Deangelis, L. M.; Holland, E.; Lacouture, M. E.; Ludwig, E.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Two cases of Erdheim-Chester disease (ECD) mimicking infratentorial malignancy
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Heaney, M.; Carrasquillo, J.; Krauthamer, A.; Nolan, C.; Kaley, T. J.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save